Effect of dose and ointment application technique on nitroglycerin plasma concentrations
- PMID: 6406987
Effect of dose and ointment application technique on nitroglycerin plasma concentrations
Abstract
Each of ten non-smoking, healthy male volunteers between the ages of 20 and 30 and within 10% of their ideal body weight received four nitroglycerin ointment (NTG-O) treatments: 1/2" NTG-O over 3.94 in2 and 7.88 in2, and 1" NTG-O over 3.94 in2 and 7.88 in2 in a randomized order. Eleven blood samples and 22 determinations of heart rate and blood pressure were obtained over each 6-hour study period. Nitroglycerin plasma concentrations were determined by gas-liquid chromatography with electron capture detection. Area under the nitroglycerin plasma concentration-time curve (AUC), peak plasma concentration (Cmax), and time to peak concentration (Tmax) were determined for each study. Cmax and AUC values were corrected for the actual dose applied. Differences between AUC, Cmax and Tmax were tested using repeated measures analysis of variance. Change in surface area had no statistically significant effect on AUC, Cmax and Tmax. Mean AUC for the 1/2" and 1" doses differed (648 vs 2003 ng.ml-1 min, p = 0.016), as did Cmax (4.6 vs 12.4 ng.ml-1, p = 0.022); however, there was no correlation between individual doses and AUCs. Generally, NTG plasma concentrations within the proposed therapeutic range of 1.2-11.1 ng.ml-1 were detectable throughout each study interval. These data suggest that continuous absorption occurred throughout the 6-hour dosing interval, that a trend toward increased AUC and Cmax occurred with the larger surface area, and that, in general, doubling the dose of NTG-O doubles the AUC.
Similar articles
-
Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.Int J Clin Pharmacol Ther. 1997 Aug;35(8):324-8. Int J Clin Pharmacol Ther. 1997. PMID: 9266287 Clinical Trial.
-
Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.Arzneimittelforschung. 1997 Jun;47(6):716-8. Arzneimittelforschung. 1997. PMID: 9239449 Clinical Trial.
-
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.Clin Ther. 2006 May;28(5):715-24. doi: 10.1016/j.clinthera.2006.05.016. Clin Ther. 2006. PMID: 16861093 Clinical Trial.
-
Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.Clin Ther. 2009 May;31(5):1022-36. doi: 10.1016/j.clinthera.2009.05.005. Clin Ther. 2009. PMID: 19539103 Clinical Trial.
-
Nitroglycerin stability: effects on bioavailability, assay and biological distribution.J Clin Hosp Pharm. 1981 Dec;6(4):227-32. doi: 10.1111/j.1365-2710.1981.tb00998.x. J Clin Hosp Pharm. 1981. PMID: 6802877 Review.
Cited by
-
Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.Clin Pharmacokinet. 1987 Jan;12(1):1-11. doi: 10.2165/00003088-198712010-00001. Clin Pharmacokinet. 1987. PMID: 3102143 Review.
-
Influence of posture on plasma nitroglycerin.Br J Clin Pharmacol. 1985 Mar;19(3):403-4. doi: 10.1111/j.1365-2125.1985.tb02661.x. Br J Clin Pharmacol. 1985. PMID: 3921046 Free PMC article. No abstract available.
-
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.Clin Pharmacokinet. 1988 Jul;15(1):32-43. doi: 10.2165/00003088-198815010-00003. Clin Pharmacokinet. 1988. PMID: 3135973 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources